Browsing NTNU Open by Author "Fosså, Alexander"
Now showing items 1-10 of 10
-
Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin’s lymphoma; symptom burden and quality of life
Eikeland, Siri A.; Smeland, Knut Bjøro; Mols, Floortje; Fagerli, Unn-Merete; Bersvendsen, Hanne Skjerven; Kiserud, Cecilie E.; Fosså, Alexander (Peer reviewed; Journal article, 2021)Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of Hodgkin’s lymphoma (HL) treatment. We aimed to describe the prevalence of CIPN associated symptoms in long-term HL survivors ... -
Chronic fatigue in long-term survivors of Hodgkin’s lymphoma after contemporary risk-adapted treatment
Eikeland, Siri Asheim; Smeland, Knut Bjøro; Simensen, Victoria C; Fagerli, Unn Merete; Bersvendsen, Hanne Skjerven; Kiserud, Cecilie E.; Fosså, Alexander (Peer reviewed; Journal article, 2023)Background Chronic fatigue (CF), substantial fatigue for ≥ six months, can manifest as a late effect (LE) after cancer treatment, and may affect several aspects of life. In a Norwegian cohort of Hodgkin’s lymphoma ... -
Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity
Smeland, Knut Bjøro; Loge, Jon Håvard; Aass, Hans Christian Dalsbotten; Aspelin, Trude; Bersvendsen, Hanne Skjerven; Bolstad, Nils; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein; Fosså, Alexander; Holte, Harald; Lund, May-Brith; Murbræch, Klaus; Reinertsen, Kristin Valborg; Stenehjem, Jo Steinson; Kiserud, Cecilie E. (Journal article; Peer reviewed, 2018) -
Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway
Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein; Fosså, Alexander; Kolstad, Arne; Loge, Jon Håvard; Maisenhölder, Martin; Kvaløy, Stein Olav; Holte, Harald (Journal article; Peer reviewed, 2015) -
The feasibility of a multidimensional intervention in lymphoma survivors with chronic fatigue
Bøhn, Skh; Oldervoll, Line Merethe; Reinertsen, Kristin Valborg; Selland, Mette; Fosså, Alexander; Kiserud, Cecilie E.; Skaali, Tone Margrethe Olsbu; Nilsen, Tormod Skogstad; Blomhoff, Rune; Henriksen, Hb; Lie, Hc; Berge, Torkil; Fjerstad, Elin; Wisløff, Torbjørn; Slott, M.; Zajmovic, I.; Thorsen, Lene (Peer reviewed; Journal article, 2024) -
A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
Hoel, Fredrik; Hoel, August; Pettersen, Ina Katrine Nitschke; Rekeland, Ingrid Gurvin; Risa, Kristin; Alme, Kine; Sørland, Kari; Fosså, Alexander; Lien, Katarina; Herder, Ingrid; Thurmer, Hanne; Gotaas, Merethe Otelie Eide; Schäfer, Christoph; Berge, Rolf K.; Sommerfelt, Kristian; Marti, Hans Peter; Dahl, Olav; Mella, Olav; Fluge, Øystein; Tronstad, Karl Johan (Peer reviewed; Journal article, 2021)Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging evidence supports that energy metabolism is affected in ME/CFS, but a unifying metabolic ... -
Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study
Lia, Kjersti; R.K. Jørgensen, Rasmus; Wold, Bente Loftum; Fluge, Øystein; Fagerli, Unn Merete; Bersvendsen, Hanne Skjerven; Bø, Idun Bakke; Bhargava, Sameer; Fosså, Alexander (Peer reviewed; Journal article, 2023)Elderly Hodgkin Lymphoma (HL) patients are poorly characterized and underrepresented in studies. In this national population-based study, we investigated cause-specific survival using competing-risk analysis in elderly HL ... -
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group
Pulczynski, Elisa J.; Kuittinen, Outi; Erlanson, Martin; Hagberg, Hans; Fosså, Alexander; Eriksson, Mikael; Nordström, Marie; Østenstad, Bjørn; Fluge, Øystein; Leppä, Sirpa; Fiirgaard, Bente; Bersvendsen, Hanne; Fagerli, Unn-Merete (Journal article; Peer reviewed, 2015)The Nordic Lymphoma Group has conducted a phase ll trial in newly diagnosed primary central nervous system lymphoma patients applying an age-adjusted multi-agent immunochemotherapy regimen, which in elderly patients included ... -
Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma
Simensen, Victoria C.; Smeland, Knut Bjøro; Kiserud, Cecilie E.; Dahl, Alv A; Bersvendsen, Hanne Skjerven; Fluge, Øystein; Fagerli, Unn-Merete; Fosså, Alexander (Journal article; Peer reviewed, 2019)Purpose: Lymphoma survivors after high dose therapy with autologous stem cell therapy (HD-ASCT) are at high risk for late adverse effects (AEs). Information patients receive and collect throughout their cancer trajectory ... -
Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects
Dahl, Alv A; Smeland, Knut Bjøro; Eikeland, Siri Asheim; Fagerli, Unn Merete; Bersvendsen, Hanne Skjerven; Fosså, Alexander; Kiserud, Cecilie E. (Peer reviewed; Journal article, 2023)Purpose We studied work-related issues in long-term survivors of Hodgkin lymphoma [HLSs] who had undergone treatment according to contemporary stage risk-adapted approaches. At survey, work changes and problems since ...